Search

everythinglearnresearchcommunity

for

Search:↓

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Abnormal ECM and immune cell interactions can cause skin diseases.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Certain cytokines and growth factors can inhibit hair growth and may affect alopecia areata.

Stem cell vesicles can reduce skin aging from UVB by lowering inflammation and oxidative stress.

Deleting the CDSN gene causes severe skin and hair problems, leading to death.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Entospletinib effectively prevents eye and skin GVHD in mice.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.